Multicenter analytical evaluation of a high-sensitivity troponin T assay

Clinica Chimica Acta

Volumn 412, Issue 9-10, 2011, Pages 748-754

  Saenger, A K ^a   Beyrau, R ^b   Braun, S ^c   Cooray, R ^d   Dolci, A ^e   Freidank, H ^b   Giannitsis, E ^f   Gustafson, S ^g   Handy, B ^g   Katus, H ^f   Melanson, S E ^h   Panteghini, M ^e   Venge, P ^d   Zorn, M ^f   Jarolim, P ^h   Bruton, D ⁱ   Jarausch, J ^j   Jaffe, A S ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ Roche Diagnostics Corporation   (United States)

^j ROCHE DIAGNOSTICS GMBH   (Germany)

more..

Author keywords

99th percentile; Acute myocardial infarction; Cardiac biomarkers; High sensitivity; Troponin

Indexed keywords

TROPONIN T;

ACCURACY; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; DIAGNOSTIC VALUE; EUROPE; FEMALE; HUMAN; INCUBATION TIME; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REFERENCE VALUE; SENSITIVITY ANALYSIS; UNITED STATES;

ADULT; AGED; DATA COLLECTION; FEMALE; HUMANS; IMMUNOASSAY; INTERNATIONALITY; LABORATORIES; LIMIT OF DETECTION; LINEAR MODELS; MALE; MIDDLE AGED; REFERENCE VALUES; TROPONIN T; YOUNG ADULT;

EID: 79951727247     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.12.034     Document Type: Article

References (29)

1. Thygesen K., Alpert J., White H., Jaffe A., Apple F., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
2. Morrow D., Cannon C., Jesse R., Newby L., Ravkilde J., Storrow A., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007, 53:552-574.
3. Wu A.H., Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M., Valdes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999, 45:1104-1121.
4. MacRae A., Kavsak P., Lustig V., Bhargava R., Vandersluis R., Palomaki G., et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem 2006, 52:812-818.
5. Apple F.S., Pearce L.A., Smith S.W., Kaczmarek J.M., Murakami M.M. Use of VITROS troponin I ES assay for early diagnosis of myocardial infarction and predicting of adverse events: role of following deltas. Clin Chem 2009, 55:930-937.
6. Giannitsis E., Becker M., Kurz K., Hess G., Zdunek D., Katus H.A. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010, 56:642-650.
7. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
8. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
9. Melanson S.E., Morrow D.A., Jarolim P. Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity. Am J Clin Pathol 2007, 128:282-286.
10. Apple F.S., Smith S.W., Pearce L.A., Ler R., Murakami M.M. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008, 54:723-728.
11. Kavsak P.A., Wang X., Ko D.T., MacRae A.R., Jaffe A.S. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009, 55:1809-1815.
12. Omland T., de Lemos J.A., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.A., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009, 361:2538-2547.
13. Latini R., Masson S., Anand I., Missov E., Carlson M., Vago T., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
14. Wu A.H., Jaffe A.S. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008, 155:208-214.
15. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:254-261.
16. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chem Acta 2009, 402:88-93.
17. Tholen D.W., Kallner A., Kennedy J.W., Krouwer J.S., Meier K. Evaluation of precision performance of quantitative measurement methods; approved guideline-second edition. CLSI EP5-A2 2004, 24(25).
18. Tholen D.W., Linnet K., Kondratovich M., Armbruster D.A., Garrett P.E., Jones R.L., et al. Protocols for determination of limits of detection and limits of quantitation; approved guideline-second edition. CLSI EP17-A 2004, 24(34).
19. Reed A.H., Henry R.J., Mason W.B. Influence of statistical method used on the resulting estimate of normal range. Clin Chem 1971, 17:275-284.
20. Panteghini M., Pagani F., Yeo K.T., Apple F.S., Christenson R.H., Dati F., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004, 50:327-332.
21. Mingels A., Jacobs L., Michielsen E., Swaanenburg J., Wodzig W., van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009, 55:101-108.
22. Jarausch J., Braun S., Dolci A., Jaffe A., Muhlbacher A., Olven C., et al. Evaluation of a development version of the Elecsys® high sensitive troponin T assay. Clin Chem 2008, 54:A91.
23. Apple F.S. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009, 55:1303-1306.
24. Matyal R. Newly appreciated pathophysiology of ischemic heart disease in women mandates changes in perioperative management: a core review. Anesth Analg 2008, 107:37-50.
25. Zethelius B., Johnston N., Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year old men. A community-based cohort study. Circulation 2006, 113:1071-1078.
26. Eggers K.M., Jaffe A.S., Lind L., Venge P., Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009, 55:85-92.
27. Stearns J.D., Davila-Roman V.G., Barzilai B., Thompson R.E., Grogen K.L., Thomas B., et al. Prognostic value of troponin I levels for predicting adverse cardiovascular outcomes in post-menopausal women undergoing cardiac surgery. Anesth Analg 2009, 108:719-726.
28. Wu A.H., Lu Q.A., Todd J., Moecks J., Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009, 55:52-58.
29. Vasile V.C., Saenger A.K., Kroning J.M., Jaffe A.S. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:1086-1090.